EcoR1 Capital, LLC, Director, 10% Owner at Zymeworks Inc. (ZYME), bought 280,808 shares at $14.01 ($3.8M) on 2025-01-15, disclosed to the SEC on 2025-01-15.
Open-market purchase of $3.8M ZYME by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.39 | 74,125 | $993K | 26.0% |
| 2 | $13.39 | 74,125 | $993K | 26.0% |
| 3 | $13.56 | 54,500 | $739K | 19.4% |
| 4 | $14.01 | 39,029 | $547K | 14.3% |
| 5 | $14.01 | 39,029 | $547K | 14.3% |
| Total | $13.60 avg | 280,808 |
| $3.8M |
| 100% |
| Filing → |
| AKTS | BUY | 2026-01-12 | $40.0M | — | Filing → |
| ADAP | SELL | 2025-07-30 | $13.2M | — | Filing → |
| ZYME | BUY | 2025-05-19 | $1.3M | — | Filing → |